Sort   by:  
 Page size 
Triple-negative breast cancer (TNBC) is an aggressive subtype with limited treatment options, characterized by high relapse rates and poor survival outcomes due to chemoresistance. This study aimed to repurpose FDA-approved drugs to overcome chemoresistance in TNBC and elucidate their mechanisms of ...
ORGANISM(S): Homo Sapiens (human) 

Overcoming resistance to chemotherapies remains a major unmet need for cancers such as triple negative breast cancer (TNBC). Therefore, mechanistic studies to provide insight for drug development are urgently needed to overcome TNBC therapy resistance. Recently, an important role of fatty acid β-...

2022-05-31 | MTBLS4709 | MetaboLights
Background: Resistance to chemotherapy remains an obstacle for triple-negative breast cancer (TNBC) patients. The core components of the ubiquitin-proteasome system have been demonstrated to regulate chemoresistance of TNBC. As a novel DUB, ubiquitin-specific peptidase 51 (USP51) plays a pivotal rol...
ORGANISM(S): Homo sapiens 
2025-11-20 | GSE248421 | GEO
USP51-GRP78 axis promotes doxorubicin-resistance by regulating the activity of ABCB1 in TNBC
Sort   by:  
 Page size